Next on Health Link: Targeted Therapies

Rather than one size fits all treatment for life threatening diseases, science is developing therapies specific to your condition. Some of that pioneering research is happening here in the capital region. On Health Link we examine the exciting field of targeted therapy. From using neural stem cells to develop therapies for eye, brain and spinal cord disorders to individualized treatment for cancer, without the toxic side effects. 

Watch Thursday August 27, 2015 at 7:30pm and
Sunday, August 30, 2015 at 10am

Xtra Dose | Targeted Therapies

Xtra Dose | Targeted Therapies

Learn more about the exciting field of medical targeted therapies.

Dr. Jeffrey Ross on Cancer Genetic DNA Sequencing

Dr. Jeffrey Ross on Cancer Genetic DNA Sequencing

Dr. Jeffrey Ross, Medical Director of Foundation Medicine, on genetic DNA sequencing.

Dr. Jeffrey Ross on Targeted Therapy

Dr. Jeffrey Ross on Targeted Therapy

Dr. Jeffrey Ross, Medical Director of Foundation Medicine, on how targeted therapy works.

Dr. Jeffrey Ross on Traditional Treatment & Targeted Therapy

Dr. Jeffrey Ross on Traditional Treatment & Targeted Therapy

Dr. Jeffrey Ross, Medical Director, on traditional treatment vs. targeted therapy.

Dr. Jeffrey Ross on Advanced Cancer and Targeted Therapy

Dr. Jeffrey Ross on Advanced Cancer and Targeted Therapy

Dr. Jeffrey Ross, Medical Director, on targeted therapy's effects on advanced cancer.

GUESTS

Jeffrey Ross, MD
Dr. Jeffrey Ross is the Medical Director of Foundation Medicine in Cambridge Massachusetts.  Dr. Ross is a leader in the field of molecular diagnostics, having received a number of academic awards, been awarded three patents and authored more than 600 peer-reviewed scientific articles and abstracts, four textbooks and numerous book chapters in the fields of pathology, molecular diagnostics, oncology and translational cancer research.  Dr. Ross is the Cyrus Strong Merrill Professor and Chair of the Department of Pathology and Laboratory Medicine at Albany Medical College, where he directs an extramurally funded research laboratory in molecular pathology.

Ira L. Zackon, MD
Dr. Ira Zackon specializes in Medical Oncology and Hematology and is Director of the NYOH Stem Cell Transplant Program.

Gary Vogt
Gary Vogt was diagnosed with myelofibrosis in 2014. He has had success with targeted therapy and shares his story.

Lori Sames
Lori Sames is the CEO and Co-Founder Hannah's Hope Fund. Lori’s daughter, Hannah, was diagnosed with Giant Axonal Neuropathy (GAN) in March of 2008. From that moment forward her life has been dedicated to a treatment and cure of GAN, and making lasting memories for her family. 

Sally Temple, PhD
Dr. Sally Temple is the co-Founder, Principal Investigator and Scientific Director of the Neural Stem Cell Institute located in Rensselaer, NY. Dr. Temple leads a team of 30 researchers focused on using neural stem cells to develop therapies for eye, brain and spinal cord disorders. Dr. Temple is recipient of many prestigious awards including the Jacob Javitz Merit award from NIH (2003) as well as the MacArthur fellowship Award (2008) in recognition of her contributions to neural stem cell developmental biology.

RESOURCES

National Cancer Institute (NCI)

American Cancer Society

-----

Disclaimer: This information is not intended to be medical advice. By clicking the links above, you will be leaving WMHT.org. WMHT Educational Telecommunications has *not* made any determination about the quality of the information within these links, nor does it endorse any information, service, product or company included within the links above.

Stock Photos provided by BigStock.

 

Underwriting Provided By:

St. Peter's Health Partners

NPR Health News

Next Avenue News

‘I Have a Dream': Music From That Memorable Day

Fifty-two years ago, on Aug. 28, 1963, Martin Luther King, Jr. delivered his “I Have a Dream” speech, which became a...